Plastic Surgery Predictions For This Year

Sometimes it is hard to keep up with all the new news coming out of the US pertaining to Cosmetic Surgery. The lovely people over at The American Society of Aesthetic Plastic Surgery (ASAPS) certainly have been keeping us busy of late with all of their new studies, they take some getting through but we like nothing more here at UCompare Towers.

ASAPS predictions for this year are a result of their interviewing many of the worlds top cosmetic surgeons to find out what developments they are seeing coming through at their own practices.

For starters any regulars to this blog will know that there has been a amazing increase in the diversity of patients considering undertaking cosmetic surgery over the last ten years. This trend is expected to continue apace as new procedures are developed to appeal to an ever widening audience within an ever increasing population.

The continued entry into the market of new providers of cosmetic fillers is likely to continue the desire for procedures involving cosmetic fillers such as Juvederm. As a relatively simple procedure, cosmetic filler applications are certainly on the increase.

We already know there is a much heightened awareness of the health implications of obesity, pleasingly this has led to increasing numbers of people making a concerted effort to loss weight, often considerable amounts. Inevitably where this is occurring there is an inevitable increase in procedures being undertaken to assist with realigning the body's contours post weight lose. Cosmetic surgery procedures such as lower body lifts, arm lifts, and abdominoplasty are likely to rise over the coming year.

There is a good chance that Reloxin, which is a form of botulinum, will gain approval from the Food & Drug Administration this year. If this does occur then it will compete directly with Botox. Botox has been by some margin the most popular cosmetic surgery procedure for the last half decade. Given the size of the market that Botox currently has all to itself it is likely that further products of a similar nature will also enter pre-market clinical trials over the coming year. All in all there is likely to be quite a scrap for market share in this category of cosmetic surgery, which could well lead to downward pressure on the current pricing of Botox procedures.....again time will tell.

Pop back tomorrow for more predictions for the coming year at your favourite cosmetic surgery blog from the good people at UCompare Cosmetic Surgery.